Ropivacaine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ropivacaine Hydrochloride Injection (injection) from Somerset Therapeutics, LLC with status Current. The shortage was first posted on 03/23/2018.
Shortage Details
- Status
- Current
- Company
- Somerset Therapeutics, LLC
- Package NDC
- 70069-067-25
- Dosage Form
- Injection
- Presentation
- Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25)
- Initial Posting
- 03/23/2018
- Revised Date